Medios AG (MEDOF)
MEDOF Stock Price Chart
Explore Medios AG interactive price chart. Choose custom timeframes to analyze MEDOF price movements and trends.
MEDOF Company Profile
Discover essential business fundamentals and corporate details for Medios AG (MEDOF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
10 Nov 2021
Employees
472.00
Website
https://www.medios.agCEO
Matthias Gaertner
Description
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
MEDOF Financial Timeline
Browse a chronological timeline of Medios AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at $0.25 falling short of the estimated $0.29 by -16.23%, while revenue for the quarter reached $507.06M , missing expectations by -14.59%.
Earnings released on 13 May 2025
EPS came in at $0.25 , while revenue for the quarter reached $484.66M .
Earnings released on 31 Dec 2024
EPS came in at $0.09 , while revenue for the quarter reached $482.53M .
Earnings released on 12 Nov 2024
EPS came in at $0.16 , while revenue for the quarter reached $493.24M , missing expectations by -18.33%.
Earnings released on 13 Aug 2024
EPS came in at $0.10 falling short of the estimated $0.19 by -48.73%, while revenue for the quarter reached $451.04M , missing expectations by -8.46%.
Earnings released on 7 May 2024
EPS came in at $0.17 , while revenue for the quarter reached $456.22M .
Earnings released on 30 Dec 2023
EPS came in at $0.10 , while revenue for the quarter reached $441.25M .
Earnings released on 30 Sept 2023
EPS came in at $0.30 surpassing the estimated $0.30 by +0.81%, while revenue for the quarter reached $489.94M , beating expectations by +0.21%.
Earnings released on 30 Jun 2023
EPS came in at $0.19 falling short of the estimated $0.25 by -25.71%, while revenue for the quarter reached $422.28M , missing expectations by -10.92%.
Earnings released on 30 Mar 2023
EPS came in at $0.11 falling short of the estimated $0.27 by -59.26%, while revenue for the quarter reached $431.24M .
Earnings released on 31 Dec 2022
EPS came in at $0.10 , while revenue for the quarter reached $399.38M .
Earnings released on 10 Nov 2022
EPS came in at $0.25 , while revenue for the quarter reached $419.22M , beating expectations by +1.61%.
Earnings released on 11 Aug 2022
EPS came in at $0.21 , while revenue for the quarter reached $399.22M , missing expectations by -3.71%.
Earnings released on 11 May 2022
EPS came in at $0.21 falling short of the estimated $0.24 by -13.72%, while revenue for the quarter reached $392.96M , missing expectations by -10.73%.
Earnings released on 31 Dec 2021
EPS came in at -$0.12 , while revenue for the quarter reached $368.64M .
Earnings released on 9 Nov 2021
EPS came in at $0.17 , while revenue for the quarter reached $353.84M .
Earnings released on 12 Aug 2021
EPS came in at $0.17 , while revenue for the quarter reached $319.02M .
Earnings released on 11 May 2021
EPS came in at $0.14 , while revenue for the quarter reached $315.91M .
Earnings released on 31 Dec 2020
EPS came in at $0.11 , while revenue for the quarter reached $173.64M .
Earnings released on 12 Nov 2020
EPS came in at $0.07 , while revenue for the quarter reached $160.02M .
MEDOF Stock Performance
Access detailed MEDOF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.